Current status and prospects of polyethyleneglycol-modified medicines
H Ishihara - Biological and Pharmaceutical Bulletin, 2013 - jstage.jst.go.jp
Polyethyleneglycol (PEG) compounds have a large hydrogen bonding capability and
possess various functions that depend on the length of the chain and conformational …
possess various functions that depend on the length of the chain and conformational …
HCV NS5A replication complex inhibitors. Part 4.1 optimization for genotype 1a replicon inhibitory activity
DR St. Laurent, MH Serrano-Wu… - Journal of Medicinal …, 2014 - ACS Publications
A series of symmetrical E-stilbene prolinamides that originated from the library-synthesized
lead 3 was studied with respect to HCV genotype 1a (G-1a) and genotype 1b (G-1b) …
lead 3 was studied with respect to HCV genotype 1a (G-1a) and genotype 1b (G-1b) …
Dual versus triple therapy in treatment of hepatitis C virus (HCV)
N Bishai, W Nabawy, ME Fiki, M Ibrahim… - Irish Journal of Medical …, 2023 - Springer
Background The goal of HCV treatment is eradication of the virus to prevent complications
associated with the disease and decrease all-cause mortality. This work compared …
associated with the disease and decrease all-cause mortality. This work compared …
[PDF][PDF] Patients with Hepatitis C on Direct-Acting Antiviral Agents' Response to the Elimination Program in Dammam City within 2018-2020
MS Fawzy, SA AlSadrah - researchgate.net
Abstract Background: Hepatitis C virus (HCV) is a worldwide health challenge that imposes
urgent interventions for prevention and control. We aimed to assess the response rate for the …
urgent interventions for prevention and control. We aimed to assess the response rate for the …